5RYABOVA T R, SOKOLOV A A, DUDKO V A, et at.Dynamics of left ventricular remodeling in patients with acute myocardial infarction[J]. Kardiologiia, 2002,42 (9) : 30-44.
6NAGAYA N, NISHIKIMI T, GOTO Y, et al. Sustained elevation of plasma brain natriuretic peptide is a biochemical marker for the prediction of progresive ventricular remodeling after acute myocardial infarction[J]. Am Heart J, 1998,135( 1):21-28.
7GARCIA E, SPAULDING C, CORCOS T, et al. Stent implantation in acute myocardial infarction[J]. Am J Cardiol,1996,77(11):451-454.
8VENUGOPAL J. Cardiac natriuretic peptide-hope or hype?[J]. J Clin Pharmacol Ther, 2001,26 ( 1 ) : 15-31.
9GRANTHAM J A, BUNETT J C. BNP: increasing importance in the pathophysiology and diagnosis of congestive heart failure[J]. Circulation, 1997,96(2) : 386-390.
4Shen WF,Fletcher PJ,Roubin GS,et al.Relation between left ventricular functional reserve during exercise and resting systolic loading conditions in chronic aortic regurgitation[J].Am J Cardiol,1986,58(9):757-761.
6Pfeffer MA,Braunwald E.Ventricular remodeling after myocardial infarction.Experimental observations and clinical implications[J].Circulation,1990,81(4):1161-1172.
7Gao XM,Dart AM,Dewar E,et al.Serial echocardiographic assessment of left ventricular dimensions and function after myocardial infarction in mice[J].Cardiovasc Res,2000,45(2):330-338.
8Sutton MG,Sharpe N.Left ventricular remodeling after myocardial infarction:pathophysiology and therapy[J].Circulation,2000,101(25):2981-2988.
8Maisel A S. Nesiritide : a new therapy for the treatment of heart failure. Cardiovasc Toxicol,2003,3 ( 1 ) :3742.
9Mccullough PA. Clinical applications of B-type natriuretic peptide levels in the care of cardiovascular patients. Minerva Cardioan-giol, 2004, 52 : 479-489.
10Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure N Engl J Med, 2002, 347: 161.
